Time | Schedule | Schedule |
---|---|---|
08.00 - 09.00 |
SYMPOSIUM 1:
Emergency Chest Pain Dilemmas: Spotting Myocardial Infarction Without Missing the Real Threat
|
SYMPOSIUM 2:
Cardiovascular Disease in Specific Population: Focus On Women and Pregnancy
|
08.00 - 08.15 | When Myocardial Infarction Mimics Non-myocardial Infarction: ECG Clues for Occlusive vs. Non-Occlusive MI | Navigating Pregnancy with Heart Disease : Current Perspectives |
08.15 - 08.30 | When Non-ACS Looks Like ACS: Avoiding Pitfalls in Diagnosis & Management | Ensuring Maternal & Fetal Safety: Pregnancy Challenges in Women with Congenital Heart Disease |
08.30 - 08.45 | From Bench to Bedside: The 2025 ESC Playbook for Myocarditis & Pericarditis | Cardiovascular Diseases in Women: Choosing Effective yet Safe Women Contraceptives |
08.45 - 09.00 | Discussion | Discussion |
09.00 - 09.30 | Opening Ceremony | |
09.30 - 10.10 | Plenary Session | |
10.10 - 10.25 | Coffee Break | |
10.25 - 11.25 |
SYMPOSIUM 3:
Hypertension Updates: Cut-off Blood Pressure and Treatment
|
SYMPOSIUM 4:
Beta Blocker in Hypertensive Emergencies
|
10:25 - 10:40 | Elevated Blood Pressure : New Concept in Hypertension | The Pathophysiology of Hypertensive Emergency: A Focus on the Sympathetic Nervous System |
10:40 - 10:55 | Monotherapy vs Fixed Dose Combination in Hypertension : Choosing Right Therapy For Different Population | Current Updates in the Diagnosis and Treatment of Hypertensive Emergencies |
10:55 - 11:10 | Hypertension Screening in Children to Prevent Premature Cardiovascular Mortality | Revisiting the Role of Intravenous Beta-blocker in Hypertensive Emergency Management |
11:10 - 11:25 | Discussion | Discussion |
11:25 - 12:25 |
LUNCH SYMPOSIUM 1 :
A-Z Comprehensive Management of Heart Failure to Improve Patient Outcomes
|
LUNCH SYMPOSIUM 2:
From Guidelines to Game-Changers: Comprehensive ASCVD Management and the Transformative Role of PCSK9-Inhibitors
|
11:25 - 11:45 | Bridging evidences of Dapagliflozin mortality benefit in heart Failure across ejection fractions and sub-populations | The Call for Comprehensive ASCVD Management: Latest Updates in Dyslipidemia Guidelines |
11:45 - 12:05 | Advancing hyperkalemia management with novel potassium binders to optimize GDMT and cardiorenal protection | Transformative role of PCSK9-Inhibitor: Breakthrough in modern lipid management |
12:05 - 12:25 | Discussion | Discussion |
12:25 - 13:25 | LUNCH BREAK | |
13:25 - 14:30 |
SYMPOSIUM 5:
Revascularization in Heart Failure Patient
|
SYMPOSIUM 6:
Syncope Management in Daily Practice
|
13:25 - 13:45 | Mechanism of Myocardial Ischemia | Transient Loss of Consciousness: Syncope or Not Syncope |
13:45 - 14:00 | How to deal with Microvascular Angina | Managing Vasovagal Syncope |
14:00 - 14:15 | The Benefit of Long term Beta-blocker treatment Post MI | Red Flag ECG Findings in Syncope |
14:15 - 14:30 | Discussion | Discussion |
14:30 - 15:30 |
SYMPOSIUM 7:
Structural and Valvular Heart Diseases (Case-based debate session)
|
SYMPOSIUM 8:
Flying to The Heart Failure Galaxy
|
14:30 - 14:45 | The Role of Pharmacological Therapy in Aortic Valve Disease: Scientifically Proven or Just Common Beliefs? | Cardiac Remodelling in Heart Failure : What Do We Know So Far? |
14:45 - 15:00 | Intervention for Aortic Valve Diseases: Transcatheter vs. Surgery | Heart Failure with Recovered Ejection Fraction : Business as Usual or Else? |
15:00 - 15:15 | Is it a bioprosthetic or mechanical valve? Optimizing Aortic Valve Replacement in the Elderly | Conquering The Heart Failure Continuum : The Guardiance of The All |
15:15 - 15:30 | Discussion | Discussion |
15:30 - 15:45 | Coffee Break | |
14:30 - 15:30 |
SYMPOSIUM 9:
Closing the Gap: Iron Deficiency Management in Heart Failure
|
CARDIOLOGY COMPETITION (CARDIOLOGY JEOPARY)
|
15:45 - 16:00 | Pathophysiology and Clinical Impact of Iron Deficiency in Heart Failure | |
16:00 - 16:15 | Diagnosis Strategies and Biomarkers of Iron Deficiency in Heart Failure | |
16:15 - 16:30 | Therapeutic Approaches : Evidence and Guideline for Iron Repletion in Heart Failure | |
16:30 - 16:45 | Discussion | |
16:45 - 17:15 | Closing Ceremony, Announcements, Doorprizes | |
19:00 - 20:00 |
HOMECOMING SESSION DINNER SYMPOSIUM : Advancing Heart Failure Management for Better Survival |
|
19.00 - 19.20 | SGLT2i : the cardiorenometabolic evidence | |
19:20 - 19:40 | Neurohormonal Modulation in Heart Failure: The Robust Evidence Behind Modern Therapies | |
19:40 - 20:00 | Discussion |